# Sagimet Biosciences Inc.: filings

SGMT · Nasdaq · CIK 1400118 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sgmt.md) · [Financials](/companies/sgmt/financials.md) · [Filings](/companies/sgmt/filings.md) · [Insiders](/companies/sgmt/insiders.md)

## Reports and events: 77 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 80, 8-K 53, 3 20, 10-Q 10, CORRESP 7, D 7, SC 13G 7, SCHEDULE 13G/A 7, S-8 6, UPLOAD 6, 144 5, SC 13G/A 5, S-1/A 4, SCHEDULE 13G 4, 10-K 3, 424B5 3, ARS 3, DEF 14A 3, DRS 3, EFFECT 3, S-1 3, SEC STAFF LETTER 3, 424B4 2, DRS/A 2, DRSLTR 2, 424B3 1, 8-A12B 1, 8-K/A 1, CERT 1, D/A 1, DEFA14A 1, RW 1, S-1MEF 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 11:15 ET | [8-K](/filings/0001193125-26-428314.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-428314 |
| 2026-10-01 | 22:00 ET | [8-K](/filings/0001193125-26-409335.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-409335 |
| 2026-09-30 | 10:09 ET | [8-K](/filings/0001193125-26-408224.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-408224 |
| 2026-08-13 | 11:05 ET | [8-K](/filings/0001193125-26-347854.md) | 8.01 Other events | 0001193125-26-347854 |
| 2026-08-11 | 11:35 ET | [8-K](/filings/0001193125-26-343446.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-343446 |
| 2026-08-11 | 11:30 ET | [10-Q](/filings/0001193125-26-343441.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343441 |
| 2026-07-21 | 01:35 ET | [8-K](/filings/0001193125-26-309334.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-309334 |
| 2026-06-12 | 20:06 ET | [8-K](/filings/0001104659-26-073431.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-26-073431 |
| 2026-06-03 | 20:30 ET | [8-K](/filings/0001104659-26-070126.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-070126 |
| 2026-05-12 | 11:35 ET | [8-K](/filings/0001104659-26-059009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059009 |
| 2026-05-12 | 11:30 ET | [10-Q](/filings/0001104659-26-059006.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059006 |
| 2026-04-28 | 11:01 ET | [8-K](/filings/0001104659-26-049756.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-049756 |
| 2026-04-27 | 11:23 ET | [8-K](/filings/0001104659-26-049015.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-049015 |
| 2026-04-27 | 11:00 ET | [8-K](/filings/0001104659-26-048971.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-048971 |
| 2026-04-21 | 20:11 ET | [DEF 14A](/filings/0001104659-26-046006.md) | Proxy statement, period 2026-06-12 | 0001104659-26-046006 |
| 2026-04-21 | 10:01 ET | [8-K](/filings/0001104659-26-045629.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-26-045629 |
| 2026-03-11 | 11:41 ET | [8-K](/filings/0001104659-26-026146.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-026146 |
| 2026-03-11 | 11:30 ET | [10-K](/filings/0001104659-26-026140.md) | Annual report, period 2025-12-31 | 0001104659-26-026140 |
| 2026-02-02 | 12:05 ET | [8-K](/filings/0001104659-26-008925.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-008925 |
| 2025-12-18 | 12:05 ET | [8-K](/filings/0001104659-25-122272.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-122272 |
| 2025-12-17 | 12:05 ET | [8-K](/filings/0001104659-25-121819.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-121819 |
| 2025-11-13 | 12:36 ET | [8-K](/filings/0001104659-25-110852.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-110852 |
| 2025-11-13 | 12:30 ET | [10-Q](/filings/0001104659-25-110846.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110846 |
| 2025-10-23 | 20:06 ET | [8-K](/filings/0001104659-25-101819.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-101819 |
| 2025-08-22 | 12:00 ET | [8-K](/filings/0001104659-25-081630.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-25-081630 |
| 2025-08-14 | 21:02 ET | [8-K](/filings/0001104659-25-078752.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-078752 |
| 2025-08-13 | 11:36 ET | [8-K](/filings/0001104659-25-077200.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-077200 |
| 2025-08-13 | 11:30 ET | [10-Q](/filings/0001558370-25-011301.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011301 |
| 2025-06-10 | 21:17 ET | [8-K](/filings/0001104659-25-058201.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-25-058201 |
| 2025-06-04 | 10:03 ET | [8-K](/filings/0001104659-25-056160.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-056160 |
| 2025-05-08 | 10:05 ET | [8-K](/filings/0001104659-25-045791.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-045791 |
| 2025-05-08 | 10:01 ET | [10-Q](/filings/0001558370-25-006836.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006836 |
| 2025-04-30 | 20:29 ET | [8-K](/filings/0001104659-25-042566.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-042566 |
| 2025-04-30 | 20:26 ET | [DEF 14A](/filings/0001104659-25-042560.md) | Proxy statement, period 2025-06-09 | 0001104659-25-042560 |
| 2025-03-12 | 11:35 ET | [8-K](/filings/0001104659-25-022763.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-022763 |
| 2025-03-12 | 11:30 ET | [10-K](/filings/0001558370-25-002747.md) | Annual report, period 2024-12-31 | 0001558370-25-002747 |
| 2025-03-11 | 12:05 ET | [8-K](/filings/0001104659-25-022423.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-022423 |
| 2025-02-14 | 21:15 ET | [8-K](/filings/0001104659-25-014099.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-014099 |
| 2025-01-02 | 13:00 ET | [8-K](/filings/0001104659-25-000137.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-000137 |
| 2024-11-14 | 13:05 ET | [8-K](/filings/0001104659-24-118342.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-118342 |
| 2024-11-14 | 13:00 ET | [10-Q](/filings/0001558370-24-015623.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015623 |
| 2024-08-16 | 20:53 ET | [8-K](/filings/0001104659-24-090546.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-090546 |
| 2024-08-14 | 12:06 ET | [8-K](/filings/0001104659-24-089340.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-089340 |
| 2024-08-14 | 12:00 ET | [10-Q](/filings/0001558370-24-012136.md) | Quarterly report, period 2024-06-30 | 0001558370-24-012136 |
| 2024-08-01 | 12:05 ET | [8-K](/filings/0001104659-24-084645.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-084645 |
| 2024-07-02 | 21:26 ET | [8-K](/filings/0001104659-24-077430.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-077430 |
| 2024-06-13 | 10:07 ET | [8-K/A](/filings/0001104659-24-071014.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-071014 |
| 2024-06-06 | 10:03 ET | [8-K](/filings/0001104659-24-068817.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068817 |
| 2024-05-23 | 11:00 ET | [8-K](/filings/0001104659-24-064509.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-064509 |
| 2024-05-15 | 12:05 ET | [8-K](/filings/0001104659-24-061609.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-061609 |

Page 1 of 2. [Older](/companies/sgmt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.